Who holds AMLXAMYLYX PHARMACEUTICALS
8 funds on our shelf carry AMYLYX PHARMACEUTICALS — heaviest hand: XPH at 2.04% of its book.
| Fund | Weight | Fund assets | Shares held | |
|---|---|---|---|---|
| XPHState Street SPDR S&P Pharmaceuticals ETF | INDEX | 2.04% | $547M | 485,721 |
| IHEiShares U.S. Pharmaceuticals ETF | INDEX | 0.67% | $1.7B | 375,582 |
| IBBQInvesco Nasdaq Biotechnology ETF | INDEX | 0.24% | $102M | 8,879 |
| VTWGVanguard Russell 2000 Growth ETF | INDEX | 0.22% | $1B | 113,140 |
| IBBiShares Biotechnology ETF | INDEX | 0.22% | $10.7B | 835,016 |
| IWOiShares Russell 2000 Growth ETF | INDEX | 0.20% | $14.4B | 969,505 |
| VFMOVanguard U.S. Momentum Factor ETF | INDEX | 0.18% | $646M | 120,117 |
| VHTVanguard Health Care Index Fund | INDEX | 0.04% | $19B | 267,729 |
LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS